Teeft.i
Checkpoint
Istex
Racine
Checkpoint
Istex
Exploration
Accueil
Racine
Racine

Serveur d'exploration MERS - Checkpoint (Istex)

Index « Teeft.i » - entrée « Phosphorothioate »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Phosphoroselenoate < Phosphorothioate < Phosphorothioate analog  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 51.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000528 (2010) Xianbin Yang [États-Unis] ; Ellen Mierzejewski [États-Unis]Synthesis of nucleoside and oligonucleoside dithiophosphates
000535 (2010) Gerald Zon [États-Unis]Automated synthesis of phosphorussulfur analogs of nucleic acids25 years on: potential therapeutic agents and proven utility in biotechnology
000656 (2009) Short Communication
000A77 (2005) J B Opalinska [Pologne] ; A M Gewirtz [États-Unis]Rationally Targeted, Conformationally Constrained, Oxetane‐Modified Oligonucleotides Demonstrate Efficient Gene‐Silencing Activity in a Cellular System
000F06 (2001) Rosie Z. Yu [États-Unis] ; Richard S. Geary [États-Unis] ; Janet M. Leeds [États-Unis] ; Tanya Watanabe [États-Unis] ; Max Moore [États-Unis] ; Jon Fitchett [États-Unis] ; John Matson [États-Unis] ; Todd Burckin [États-Unis] ; Michael V. Templin [États-Unis] ; Arthur A. Levin [États-Unis]Comparison of pharmacokinetics and tissue disposition of an antisense phosphorothioate oligonucleotide targeting human Ha‐ras mRNA in mouse and monkey
000F53 (2000) C. A Stein [États-Unis]Is irrelevant cleavage the price of antisense efficacy?
001091 (1999) James Summerton [États-Unis]Morpholino antisense oligomers: the case for an RNase H-independent structural type
001093 (1999) Stanley T. Crooke [États-Unis]Molecular mechanisms of action of antisense drugs
001234 (1998) A. Kirk Field [États-Unis]Viral targets for antisense oligonucleotides: a mini review
001384 (1998) Rhonda M. Brand [États-Unis] ; Andrew Wahl [États-Unis] ; Patrick L. Iversen [États-Unis]Effects of size and sequence on the iontophoretic delivery of oligonucleotides
001420 (1997) H. K Tewary [États-Unis] ; P. L Iversen [États-Unis]Qualitative and quantitative measurements of oligonucleotides in gene therapy: Part I in vitro models
001434 (1997) Włodzimierz Buczko [Pologne] ; Czesław Cierniewski [Pologne] ; Anna Kobyla Ska [Pologne] ; Maria Koziołkiewicz [Pologne] ; And Rzej Okruszek [Pologne] ; Zofia Pawłowska [Pologne] ; Elzbzieta Pluskota [Pologne] ; Wojciech J. Stec [Pologne]Modulation of plasminogen activator inhibitor type-1 biosynthesis in vitro and in vivo with oligo(nucleoside phosphorothioate)s and related constructs
001530 (1997) Xiaojun Cheng [États-Unis] ; Robert K. Delong [États-Unis] ; Eric Wickstrom [États-Unis] ; M. Kligshteyn [États-Unis] ; Samuel H. Demirdji [États-Unis] ; Marvin H. Caruthers [États-Unis] ; R. L. Juliano [États-Unis]Interactions between single‐stranded DNA binding protein and oligonucleotide analogs with different backbone chemistries
001536 (1997) L. D. Graham ; I. P. Hayward [Australie] ; M. Fitzgerald [Australie] ; J. M. Whitelock ; J. A. Bingley [Australie] ; J. H. Campbell [Australie] ; P. A. UnderwoodINHIBITION OF PHENOTYPE MODULATION, GROWTH, AND MIGRATION OF VASCULAR SMOOTH MUSCLE CELLS BY A GUANOSINE-RICH 30-MER PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDE
001579 (1997) John E. Mata ; Shantaram S. Joshi ; Brian Palen ; Samuel J. Pirruccello ; John D. Jackson ; Nadia Elias ; Todd J. Page ; Kristin L. Medlin ; Patrick L. IversenA Hexameric Phosphorothioate Oligonucleotide Telomerase Inhibitor Arrests Growth of Burkitt's Lymphoma Cells in Vitro and in Vivo
001600 (1996) Satoru Tsukahara [Japon] ; Junji Suzuki [Japon] ; Kaoru Ushijima [Japon] ; Kazuyuki Takai [Japon] ; Hiroshi Takaku [Japon]Nonenzymatic sequence-specific cleavage of duplex DNA via triple-helix formation by homopyrimidine phosphorothioate oligonucleotides
001607 (1996) Olivier Zelphati [États-Unis] ; Francis C. Szoka Jr [États-Unis]Liposomes as a carrier for intracellular delivery of antisense oligonucleotides: a real or magic bullet?
001613 (1996) Mouna P. Selvam [États-Unis] ; Sheila M. Buck [États-Unis] ; Roy A. Blay [États-Unis] ; Ronald E. Mayner [États-Unis] ; P. A Mied [États-Unis] ; Jay S. Epstein [États-Unis]Inhibition of HIV replication by immunoliposomal antisense oligonucleotide
001689 (1996) Naoko Miyano-Kurosaki [Japon] ; Yoshio Koyanagi [Japon] ; Masatsugu Mizuguchi [Japon] ; Shigeji Ohki [Japon] ; Keisuke Makino [Japon] ; Naoki Yamamoto [Japon]Inhibition of HTLV-I induction and virus-induced syncytia formation by oligodeoxynucleotides
001793 (1995) Sang-Gug Kim [Japon] ; Toshifumi Hatta [Japon] ; Satoru Tsukahara [Japon] ; Hideki Nakashima [Japon] ; Naoki Yamamoto [Japon] ; Yoko Shoji [Japon] ; Kazuyuki Takai [Japon] ; Hiroshi Takaku [Japon]Antiviral effect of phosphorothioate oligodeoxyribonucleotides complementary to human immunodeficiency virus
001794 (1995) Makoto Matsukura [Japon] ; Kazuo Koike [Japon] ; Gerald Zon [États-Unis]Antisense phosphorothioates as antivirals against human immunodeficiency virus (HIV) and hepatitis B virus (HBV)

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Istex/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Teeft.i -k "Phosphorothioate" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Teeft.i  \
                -Sk "Phosphorothioate" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    Istex
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Teeft.i
   |clé=    Phosphorothioate
}}
Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021